mAb Process Development and Optimization

1. Scalable By Design: Streamlining Cell Culture Media Manufacturing 8/15/2024

   Learn ways to help improve quality, simplify technology transfer of proprietary media formulations, and mitigate logistical challenges associated with custom media scale-up processes.

2. Next-Gen Medium And Feeds System To Improve CHO Cell Line Productivity 6/19/2024

   Choose the right CHO medium and feed system to optimize your upstream processes and secure a seamless scaling up.

3. What Bioprocessing Bottlenecks Does Process Intensification Address? 8/27/2024

   Supply chains, consumables, and data are identified as three of the management challenges that intensified processes and process automation technology (PAT) are addressing at AbbVie and AstraZeneca.

4. Addressing Aggregation And Degradation In Complex Protein Therapeutics 9/13/2024

   In this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics, panelists discuss using a transient expression platform to make fast early product attribute decisions.

5. Where Process Intensification Sits In The AbbVie, AstraZeneca Organizations 8/27/2024

   In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, panelists discuss where and how their roles in setting the course for process intensification sit within their greater organizations.

6. Process Intensification Audience Q&A 8/27/2024

   Our panelists take audience questions on process intensification lessons learned from other industries.

7. The Role Of Peptones In Boosting Quality And Yield 11/4/2024

   Peptones can significantly boost CHO cell bioprocessing. We analyze their impact on diverse CHO cell lines using real-world data to assess their effects on titer, protein quality, and cell growth.

8. Three Novel Protein Therapeutic Worldviews 9/13/2024

   In this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics, we meet panelists who share their topline perspectives on developing complex, novel protein therapeutics.

9. Planning for Success: Supply Resiliency Strategies for Bench to Production 10/18/2023

   Build scalable material sourcing strategies for R&D and early phases through to commercialization and learn how to accelerate the development process and ensure the scalability of your biologics.

10. Accelerating mAb Process Development In The Growing Therapeutics Market 8/20/2024

    The market for mAbs and mAb variants is growing rapidly. Explore the latest strategies and advancements in early stage mAb up- and downstream process development.